Stocks › ZTS
Zoetis Inc.
ZTS·NYSE·
United States·USD
$79.11
-1.68 (-2.08%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
ZTS
Zoetis Inc. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ZTSS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of ZTS by members of U.S. Congress · 376 on record · 44 in the last 12 months
Whale Activity
Position changes in ZTS reported for 2026-09-30 by 1544 institutional filers
- Increased474
- New125
- Held159
- Decreased539
- Closed185
- No prior filing62
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 38.5M | $2.69B | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 25.7M | $1.80B | decreased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 23.5M | $1.64B | decreased |
| STATE STREET CORP | 19.7M | $1.38B | increased |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 15.9M | $1.11B | held |
| GEODE CAPITAL MANAGEMENT, LLC | 13.3M | $923.7M | decreased |
| FIL Ltd | 10.6M | $743.1M | increased |
| MORGAN STANLEY | 8.0M | $560.6M | decreased |
| Invesco Ltd. | 8.0M | $556.4M | increased |
| NORDEA INVESTMENT MANAGEMENT AB | 6.3M | $443.0M | decreased |
| DEUTSCHE BANK AG\ | 5.8M | $408.4M | decreased |
| VAN ECK ASSOCIATES CORP | 5.4M | $376.8M | increased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by ZTS insiders, by quarter · Form 4
Recent Insider Transactions
1,106 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| DAMELIO FRANK ADirector | Gift | −6,650 | $0.00 | $0 | Aug 7, 2026 | Form 4 ↗ |
| MCCALLISTER MICHAEL BDirector | Gift | −1,209 | $0.00 | $0 | Jun 10, 2026 | Form 4 ↗ |
| Stetter MarkDirector | Option exercise | +1,572 | — | — | May 21, 2026 | Form 4 ↗ |
| PARENT LOUISE MDirector | Option exercise | +10.2K | — | — | May 20, 2026 | Form 4 ↗ |
| PARENT LOUISE MDirector | Option exercise | +1,944 | — | — | May 20, 2026 | Form 4 ↗ |
| DAMELIO FRANK ADirector | Purchase | +6,650 | $75.39 | $501K | May 13, 2026 | Form 4 ↗ |
| Bisaro PaulDirector | Purchase | +2,000 | $75.88 | $152K | May 13, 2026 | Form 4 ↗ |
| MCCALLISTER MICHAEL BDirector | Purchase | +3,000 | $77.76 | $233K | May 11, 2026 | Form 4 ↗ |
| Esch KevinExecutive Vice President | Tax withholding | −75 | $114.97 | $9K | Apr 30, 2026 | Form 4 ↗ |
| Esch KevinExecutive Vice President | Option exercise | +259 | — | — | Apr 30, 2026 | Form 4 ↗ |
| Sarbaugh KeithExecutive Vice President | Tax withholding | −524 | $118.21 | $62K | Mar 31, 2026 | Form 4 ↗ |
| Sarbaugh KeithExecutive Vice President | Option exercise | +1,528 | — | — | Mar 31, 2026 | Form 4 ↗ |
| Norden GregoryDirector | Gift | −1,213 | $0.00 | $0 | Mar 9, 2026 | Form 4 ↗ |
| MCCALLISTER MICHAEL BDirector | Other | −413 | $127.28 | $53K | Feb 19, 2026 | Form 4 ↗ |
| MCCALLISTER MICHAEL BDirector | Option exercise | +1,619 | — | — | Feb 19, 2026 | Form 4 ↗ |
| Norden GregoryDirector | Other | −406 | $127.28 | $52K | Feb 19, 2026 | Form 4 ↗ |
| Norden GregoryDirector | Option exercise | +1,619 | — | — | Feb 19, 2026 | Form 4 ↗ |
| Broadhurst VanessaDirector | Other | −517 | $127.28 | $66K | Feb 19, 2026 | Form 4 ↗ |
| Broadhurst VanessaDirector | Option exercise | +1,619 | — | — | Feb 19, 2026 | Form 4 ↗ |
| FULLER JULIEExecutive Vice President | Tax withholding | −290 | $127.28 | $37K | Feb 19, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding ZTS · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 12.0M | $861.0M | 0.04% | Jun 30, 2026 |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 10.9M | $780.6M | 0.05% | Jun 30, 2026 |
| VANGUARD MID-CAP INDEX FUND VANGUARD INDEX FUNDS | 8.2M | $587.5M | 0.26% | Jun 30, 2026 |
| VANGUARD EQUITY INCOME FUND VANGUARD FENWAY FUNDS | 6.1M | $438.8M | 0.67% | Jun 30, 2026 |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 5.4M | $419.6M | 0.05% | Aug 31, 2026 |
| iShares Core S&P 500 ETF iShares Trust | 5.8M | $414.4M | 0.05% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | 5.1M | $365.1M | 0.05% | Jun 30, 2026 |
| VANGUARD DIVIDEND GROWTH FUND VANGUARD SPECIALIZED FUNDS | 2.4M | $281.1M | 0.76% | Apr 30, 2026 |
| VANGUARD VALUE INDEX FUND VANGUARD INDEX FUNDS | 3.6M | $258.8M | 0.10% | Jun 30, 2026 |
| VanEck Morningstar Wide Moat ETF VanEck ETF Trust | 3.7M | $257.4M | 2.29% | Sep 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list ZTS's shares (CUSIP 98978V103), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 37.7M shares9.0%
Jul 30, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming zoetis as client
- ZOETIS INC.ZOETIS INC. · 2026 Q3 · AGR, TRD, TAX, GOV$150K
Filing ↗ - WILLIAMS AND JENSEN, PLLCZOETIS · 2026 Q3 · HCR, TAX, AGR, TRD$80K
Filing ↗ - THE RUSSELL GROUP, INC.ZOETIS · 2026 Q3 · AGR$80K
Filing ↗ - ZOETIS INC.ZOETIS INC. · 2026 Q2 · AGR, TRD, TAX, GOV$300K
Filing ↗ - WILLIAMS AND JENSEN, PLLCZOETIS · 2026 Q2 · HCR, TAX, AGR, TRD$80K
Filing ↗
Government Contracts
Federal awards to zoetis · USAspending
$1.4MAwarded · 3 contracts on record
- Department of Health and Human ServicesRABIES VACCINES FOR OEHE WITH BASE AND FOUR OPTIONS$69K
Feb 24, 2022 · ↗ - Department of AgricultureCLASSICAL SWINE FEVER VIRUS (CSFV) VACCINE, DIVA, SUITABLE FOR USE IN VACCINATION PROGRAMS THAT EMPLOY DIFFERENTIATING INFECTED FROM VACCINA$1.3M
Apr 13, 2022 · ↗ - Department of Health and Human ServicesEO 14398: NAIHS OEHE RABIES VACCINES$35K
Sep 14, 2026 · ↗
U.S. Patents
Recent USPTO applications naming Zoetis Inc.
No USPTO patent applications found for Zoetis Inc..
Annual Financials
From ZTS's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $9.47B | $9.26B | $8.54B | $8.08B | $7.78B |
| Net income | $2.67B | $2.49B | $2.34B | $2.11B | $2.04B |
| Diluted EPS | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 |
| Operating cash flow | $2.90B | $2.95B | $2.35B | $1.91B | $2.21B |
| Total assets | $15.47B | $14.24B | $14.29B | $14.93B | $13.90B |
| Total liabilities | $12.14B | $9.47B | $9.29B | $10.52B | $9.36B |
| Shareholders' equity | $3.33B | $4.77B | $5.00B | $4.41B | $4.54B |
As Zoetis Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 12, 2026 ↗
Stock Splits
Every split and reverse split in the price history
No stock splits in ZTS's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 9.01Results of operationsNov 5, 2026
EDGAR ↗ - 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureOct 13, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureOct 8, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
EDGAR ↗ - 8-K · Items 5.02, 9.01Officer / director changeAug 6, 2026
EDGAR ↗ - 8-K · Items 5.02, 5.07Officer / director change · Shareholder voteMay 22, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureMay 20, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
EDGAR ↗
About Zoetis Inc.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersPARSIPPANY, NJ
SEC CIK0001555280 ↗





